Korean hyaluronic acid dermal fillers have established themselves as a genuine premium alternative to Western filler brands in European aesthetic clinics. Products like Revolax Deep and Neuramis Deep offer comparable clinical performance to market leaders like Juvederm and Restylane at 40–60% lower acquisition costs, with CE marking and extensive safety data.
Understanding Korean HA Filler Technology
The quality of a hyaluronic acid filler depends primarily on its cross-linking technology, HA concentration, particle size, and homogeneity. Korean manufacturers have invested significantly in proprietary cross-linking technologies that achieve results comparable to European market leaders:
Revolax (SHAPE technology) — Across Corp.'s proprietary cross-linking process achieves a highly cohesive, smooth gel with consistent particle size. The high degree of cross-linking results in a high G-prime and excellent longevity (12–18 months).
Neuramis (VirCross technology) — Medytox's VirCross technology produces a highly pure, biocompatible HA gel with a smooth injection experience. The moderate G-prime makes it versatile for both structural and soft-tissue applications.
Korean HA Fillers vs Western Competitors
| Revolax Deep (Korean Fillers EU) | €55/1.1ml | 24mg/ml HA | Lidocaine 0.3% | 12–18 months | CE marked |
| Neuramis Deep (Korean Fillers EU) | €37/1ml | 23mg/ml HA | Lidocaine 0.3% | 12–18 months | CE marked |
| Juvederm Ultra 3 (Allergan) | ~€120–150/1ml | 24mg/ml HA | Lidocaine 0.3% | 9–12 months | CE marked |
| Restylane Lyft (Galderma) | ~€100–130/1ml | 20mg/ml HA | Lidocaine 0.3% | 12 months | CE marked |
| Belotero Balance (Merz) | ~€80–110/1ml | 22.5mg/ml HA | Lidocaine 0.3% | 9–12 months | CE marked |
Clinical Selection Guide
Choosing between Revolax Deep and Neuramis Deep depends on the treatment area and desired outcome:
For practitioners with limited filler experience, Neuramis Deep's lower G-prime and softer formulation makes it more forgiving for lip work and delicate perioral areas. Revolax Deep's higher G-prime provides more predictable lift for deeper structural placement.
Regulatory Status in Europe
Both Revolax and Neuramis carry CE marking (Medical Device Regulation MDR 2017/745), meaning they have been independently assessed for safety and performance in the EU. This regulatory status is equivalent to the CE marking held by Juvederm, Restylane, and other market-leading filler products.
For a detailed technical comparison of Revolax versus Juvederm, see our Korean Fillers vs Juvederm comparison article.
Frequently Asked Questions
Order Revolax Deep for Your Clinic
Authentic KFDA-approved product. Fast EU delivery from €55/unit.
View Revolax Deep